TABLE 1.
Oligonucleotides used in this study
| Oligonucleotide | Type | Sequence | Reference or source |
|---|---|---|---|
| NAT1F | Forward | 5′-CATGCAGGATTCGAGTGGCATG-3′ | This study |
| NAT2R | Reverse | 5′-ATCGATAAGCTTGATTTGGCGGAGCCATGAAGATCCTGAGGA-3′ | This study |
| CTR3F | Forward | 5′-TCCTCAGGATCTTCATGGCTCCGCCAAATCAAGCTTATCGAT-3′ | This study |
| CTR4R | Reverse | 5′-CATATGGATTGGTGAAGTCG-3′ | This study |
| F1CTR1 | Forward | 5′-AAGGAACCCCGTGTATTTCC-3′ | This study |
| F1CTR2Rev | Reverse | 5′ CACTCGAATCCTGCATGCGACTCTCCTGTGCTGCGG-3′ | This study |
| F1CTR3 | Forward | 5′-CCGCAGCACAGGAGAGTCGCATGCAGGATTCGAGTG-3′ | This study |
| F1CTR4Rev | Reverse | 5′-GAAGAGAAGAGGGAGGCCATGATTGGTGAAGTCGTTGTCG-3′ | This study |
| F1CTR5 | Forward | 5′-CGACAACGACTTCACCAATCATGGCCTCCCTCTTCTCTTC-3′ | This study |
| F1CTR6Rev | Reverse | 5′-CTCGGAGACCGATGTAAAAC-3′ | This study |
| F2CTR1 | Forward | 5′-CGCAAAGGCCTTGAAGTAAG-3′ | This study |
| F2CTR2Rev | Reverse | 5′-CACTCGAATCCTGCATGCTGTGTATGTCTCCGTCGGGG-3′ | This study |
| F2CTR3 | Forward | 5′-CCCCGACGGAGACATACACAGCATGCAGGATTCGAGTG-3′ | This study |
| F2CTR4Rev | Reverse | 5′-CATCCCTTCAGCGGCCATGATTGGTGAAGTCGTTGTCG-3′ | This study |
| F2CTR5 | Forward | 5′-CGACAACGACTTCACCAATCATGGCCGCTGAAGGGATG-3′ | This study |
| F2CTR6Rev | Reverse | 5′-AGCCTTCTTGGCAAAAGTGA-3′ | This study |
| FAS1L-RT | Forward | 5′-ACGCTTCTTACAGCGGTATC-3′ | This study |
| FAS1R-RT | Reverse | 5′-CTCTCTTTGAGCGTGCTCCT-3′ | This study |
| FAS2L-RT | Forward | 5′-TGGTGCTCTCTCTGGTGTTG-3′ | This study |
| FAS2R-RT | Reverse | 5′-GACCAGCAAAGGAGGCAGTA-3′ | This study |